吉利德科學與世界肝炎聯盟及專家攜手透過 ALL4LIVER基金全球撥款400萬美元支持世衛2030年的滅肝目標,兩間香港非牟利組織受惠
Several big pharma companies are rushing into the GLP-1 obesity space, which currently has two market leaders. How they plan to take some of that market share will be the story of the drug class for 2024.
Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.